SCHEMBL4762425

SCHEMBL4762425

Cn1cc(/C=C/c2c([N+](=O)[O-])c(=O)n(Cc3ccccc3F)c(=O)n2Cc2ccccc2F)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
LMNA P02545 2/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 2/20 0.38
NPC1 O15118 1/20 0.38
PKM P14618 1/20 0.38
PKLR P30613 1/20 0.38
MAPK1 P28482 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HTT P42858 1/20 0.38
HSD17B10 Q99714 1/20 0.38
PDE1A P54750 1/20 0.37
PDE1B Q01064 1/20 0.37
PDE1C Q14123 1/20 0.37
MITF O75030 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPT P10636 4/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4767904 0.91 MAPT (0.44) ALDH1A1L3MBTL1HPGDTSHRMAPK1
SCHEMBL4764053 0.90 ALDH1A1 (0.41) ALDH1A1L3MBTL1LMNATSHRNPC1
SCHEMBL4769545 0.87 NPC1 (0.39) ALDH1A1L3MBTL1LMNANPC1PKM
SCHEMBL4765667 0.84 ADORA2A (0.40) ALDH1A1L3MBTL1PKMPKLRMAPK1
SCHEMBL4763491 0.83 ADORA2B (0.42) ALDH1A1L3MBTL1LMNANPC1PKM
SCHEMBL4763488 0.83 ADORA2B (0.42) ALDH1A1L3MBTL1LMNANPC1PKM
SCHEMBL4762383 0.82 MAPT (0.42) ALDH1A1L3MBTL1PKMMAPK1MAPT
SCHEMBL4762591 0.82 MAPT (0.37) ALDH1A1L3MBTL1LMNAPKMPKLR
SCHEMBL4763889 0.82 ADORA2B (0.46) ALDH1A1L3MBTL1LMNAPKMMAPT
SCHEMBL4769328 0.82 ADORA2B (0.49) ALDH1A1L3MBTL1PKMMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-B1 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS INC (US) 2008-12-31 EP disclosed